| CI | confidence interval |
| CMF | cyclophosphamide/methotrexate/5-fluorouracil |
| CXCL13 | chemokine leukocyte chemoattractant-ligand (C-X-C motif) 13 |
| EC | epirubicin/cyclophosphamide |
| ER | estrogen receptor |
| FADD | Fas-associated protein with death domain |
| HER2 | human epidermal growth factor receptor |
| HR | hazard ratio |
| IFN-γ | interferon-γ |
| IFNG | interferon-gamma |
| IFNGR1 | interferon-γ receptor 1 |
| IGKC | immunoglobulin kappa C |
| IRF1 | interferon regulatory factor 1 |
| JAK | Janus kinase |
| MHC | major histocompatibility complex |
| N | nodal status |
| NST | no special type |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed cell death 1 ligand 1 |
| PR | progesterone receptor |
| STAT1 | signal transducer and activator of transcription 1 |
| T | tumor size |
| Th1 | T-helper cells type I |
| TNBC | triple-negative breast cancer |
| TRAIL | tumor necrosis factor-related apoptosis-inducing ligand |